MCPP

meta-Chlorophenylpiperazine (also known as mCPP) is a stimulant drug of the phenylpiperazine class. It was first synthesized as one in a series of potential novel antihistamines by Thomas H. Wicker Jr. in 1951 as part of his doctoral work at the University of Florida. Unlike many other stimulants like amphetamine, mCPP is generally considered to be unpleasant. mCPP is notable for inducing anxiety, and causing migraines and severe headaches. mCPP is occasionally encountered as an adulterant in street MDMA.

Also known as: Cpp, 3-cpp, metachlorophenylpiperazine

Classification

Chemical: Piperazine
Psychoactive: Stimulant
Tag: Research-Chemical
Tag: substituted piperazine
Tag: Tentative

Effects

Increased Heart Rate
Stimulation
Nausea
Jaw Tension
Insomnia
Restlessness
Talkativeness
Alertness Enhancement
Euphoria
Sociability Enhancement
Anxiety
Empathy Enhancement
Light Sensitivity
Increased Music Appreciation
Auditory Enhancement
Blurred Vision
Brightness Enhancement
Contrast Enhancement

Routes of Administration

Oral

Dosage

Threshold: 15 mg
Heavy: 150 mg
Common: 50-120 mg
Light: 20-50 mg
Strong: 120-150 mg

Duration

Onset: 0.3-1 h
Comeup: 0.3-1 h
Peak: 2-4 h
Offset: 3-8 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu